Related Experiment Videos
Solid tumors in children
1Department of Surgery, Children's Hospital, Boston, Massachusetts.
Insights
Nurses play a vital role in caring for pediatric solid tumors. Continued research is needed to improve outcomes for children with advanced cancers like nephroblastoma and neuroblastoma.
Area of Science:
- Pediatric Oncology
- Nursing Care
- Solid Tumors in Children
Background:
- Pediatric solid tumors require comprehensive understanding for effective nursing care.
- Advances in pediatric cancer treatment have improved outcomes over the last 25 years.
- Specific pediatric solid tumors like nephroblastoma, neuroblastoma, hepatoblastoma (HCC), and teratoma still present challenges.
Purpose of the Study:
- To highlight the essential knowledge nurses need regarding pediatric solid tumors.
- To emphasize the ongoing need for improved outcomes in advanced pediatric cancers.
Main Methods:
- This abstract is based on a review of current knowledge and clinical practice.
- It synthesizes information on incidence, presentation, treatment, prognosis, and psychosocial aspects.
- Focuses on the nurse's role within the multidisciplinary health care team.
Main Results:
- Nurses require a holistic understanding of pediatric solid tumors to provide optimal care.
- Significant progress has been made, but challenges persist for advanced stages of certain tumors.
- Key areas for improvement include outcomes for advanced nephroblastoma, neuroblastoma, HCC, and teratoma.
Conclusions:
- Nurses are integral to the pediatric oncology health care team.
- Enhanced understanding and continued research are crucial for improving survival and quality of life for children with solid tumors.
- Further advancements are particularly necessary for high-risk pediatric cancers.
Abstract:
A thorough understanding of the incidence, clinical presentation, treatment, prognosis, and psychosocial issues surrounding children with solid tumors enables the nurse to actively participate on the health care team. Although significant advances over the past two-and-a-half decades to improve the outcomes of children with cancer have occurred, there remains room for continued improvement, especially among children with advanced-stage nephroblastoma, neuroblastoma, HCC, and teratoma.